Mechanistic and functional differentiation of tapentadol and tramadol

@article{Raffa2012MechanisticAF,
  title={Mechanistic and functional differentiation of tapentadol and tramadol},
  author={R. Raffa and H. Buschmann and T. Christoph and G. Eichenbaum and W. Englberger and C. Flores and T. Hertrampf and B. K{\"o}gel and K. Schiene and W. Strassburger and R. Terlinden and T. M. Tzschentke},
  journal={Expert Opinion on Pharmacotherapy},
  year={2012},
  volume={13},
  pages={1437 - 1449}
}
  • R. Raffa, H. Buschmann, +9 authors T. M. Tzschentke
  • Published 2012
  • Medicine
  • Expert Opinion on Pharmacotherapy
    • Introduction: Many opioid analgesics share common structural elements; however, minor differences in structure can result in major differences in pharmacological activity, pharmacokinetic profile, and clinical efficacy and tolerability. Areas covered: This review compares and contrasts the chemistry, pharmacodynamics, pharmacokinetics, and CNS ‘functional activity' of tapentadol and tramadol, responsible for their individual clinical utilities. Expert opinion: The distinct properties of… CONTINUE READING
    View on Taylor & Francis
    ncbi.nlm.nih.gov
    Top 3 of 115 Citations
    Comparative metabolism of tramadol and tapentadol: a toxicological perspective
    Joana Barbosa, J. Faria, … R. Dinis-OliveiraDrug metabolism reviews2016
    30
    Is tapentadol different from classical opioids? A review of the evidence
    R. Langford, R. Knaggs, … A. DickensonBritish journal of pain2016
    41
    Comparative pharmacology and toxicology of tramadol and tapentadol
    J. Faria, J. Barbosa, … R. Dinis-OliveiraEuropean journal of pain2018
    20
    115 Citations
    Citation Type

    Citation Type

    Comparative metabolism of tramadol and tapentadol: a toxicological perspective
    • 30
    • Highly Influenced
    Is tapentadol different from classical opioids? A review of the evidence
    • 41
    • PDF
    Comparative pharmacology and toxicology of tramadol and tapentadol
    • 20
    The Mu-Opioid Receptor Agonist/Noradrenaline Reuptake Inhibition (MOR–NRI) Concept in Analgesia: The Case of Tapentadol
    • 65
    PharmGKB summary: tramadol pathway.
    • 45
    • PDF
    Patient considerations in the use of tapentadol for moderate to severe pain
    • 61
    • PDF
    Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’
    • 27
    • PDF
    Descending pain modulation and chronification of pain
    • 200
    Tapentadol abuse potential: a postmarketing evaluation using a sample of individuals evaluated for substance abuse treatment.
    • 53
    • PDF
    Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain
    • 30

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 78 REFERENCES
    Tramadol--the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain.
    • 93
    In vitro and in vivo characterization of tapentadol metabolites.
    • 61
    [Pharmacology of tramadol].
    • 163
    Affinity, potency and efficacy of tramadol and its metabolites at the cloned human µ-opioid receptor
    • 240
    Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
    • 402
    Tapentadol and its two mechanisms of action: Is there a new pharmacological class of centrally‐acting analgesics on the horizon?
    • 108
    • Highly Influential
    Synergistic Interaction between the Two Mechanisms of Action of Tapentadol in Analgesia
    • 102
    • PDF
    Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
    • 1,066
    Role of active metabolites in the use of opioids
    • 94
    • PDF
    A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain.
    • 167
    • PDF